Načítá se...
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
Optimizing menopausal hormone therapy (MHT) requires an awareness of the benefits and risks associated with the available treatments. This narrative review, which is based on the proceedings of an Advisory Board meeting and supplemented by relevant articles identified in literature searches, examine...
Uloženo v:
| Vydáno v: | Drugs Context |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioExcel Publishing Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7716720/ https://ncbi.nlm.nih.gov/pubmed/33312219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-10-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|